Pentraxin 3 as a biomarker for acute coronary syndrome: Comparison with biomarkers for cardiac damage

Journal of Cardiology

Volumn 58, Issue 1, 2011, Pages 38-45

  Kume, Noriaki ^a   Mitsuoka, Hirokazu ^a   Hayashida, Kazutaka ^a   Tanaka, Masaru ^b  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; Diagnostic techniques; Myocardial infarction; Pathophysiology; Plaque; Unstable angina

Indexed keywords

FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTRAXIN 3; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEART INJURY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SERUM AMYLOID P-COMPONENT; TROPONIN T;

EID: 79959732193     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.03.006     Document Type: Article

References (26)

1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
2. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
3. Mach F., Lovis C., Gaspoz J.M., Unger P.F., Bouillie M., Urban P., Rutishauser W. C-reactive protein as a marker for acute coronary syndromes. Eur Heart J 1997, 18:1897-1902.
4. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
5. Miyao Y., Yasue H., Ogawa H., Misumi I., Masuda T., Sakamoto T., Morita E. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993, 126:1299-1304.
6. Mallat Z., Henry P., Fressonnet R., Alouani S., Scoazec A., Beaufils P., Chvatchko Y., Tedgui A. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 2002, 88:467-469.
7. Masaki Y., Shimada K., Kojima T., Miyauchi K., Inoue K., Kiyanagi T., Hiki M., Fukao K., Hirose K., Ohsaka H., Kume A., Miyazaki T., Ohmura H., Ohsaka A., Daida H. Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation. J Cardiol 2011, (March). [Epub ahead of print].
8. Yamashita T., Seino Y., Ogawa A., Ogata K.-I., Fukushima M., Tanaka K., Mizuno K. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. J Cardiol 2010, 55:377-383.
9. Hayashida K., Kume N., Murase T., Minami M., Nakagawa D., Inada T., Tanaka M., Ueda A., Kominami G., Kambara H., Kimura T., Kita T. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome. A novel marker for early diagnosis. Circulation 2005, 112:812-818.
10. Ueda A., Kume N., Hayashida K., Inui-Hayashida A., Asai M., Kita T., Kominami G. ELISA for soluble form of lectin-like oxidized LDL receptor-1, a novel marker of acute coronary syndrome. Clin Chem 2006, 52:1210-1211.
11. Nakamura M., Ohta H., Kume N., Hayashida K., Tanaka M., Mitsuoka H., Kaneshige T., Misaki S., Imagawa K., Shimosako K., Ogawa N., Kita T., Kominami G. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay. J Pharm Biomed 2010, 51:158-163.
12. Kume N., Mitsuoka H., Hayashida K., Tanaka M., Kita T. Soluble lectin-like oxidized low density lipoprotein receptor-1 (sLOX-1) predicts prognosis after acute coronary syndrome-a pilot study. Circ J 2010, 74:1399-1404.
13. Kume N., Mitsuoka H., Hayashida K., Tanaka M., Kominami G., Kita T. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome-comparison with other biomarkers. J Cardiol 2010, 56:159-165.
14. Rolph M.S., Zimmer S., Bottazzi B., Garlanda C., Mantovani A., Hansson G.K. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22:e10-e14.
15. Peri G., Introna M., Corradi D., Iacuitti G., Signorini S., Avanzini F., Pizzetti F., Maggioni A.P., Moccetti T., Metra M., Cas L.D., Ghezzi P., Sipe J.D., Re G., Olivetti G., et al. PTX3. A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000, 102:636-641.
16. Inoue K., Sugiyama A., Reid P.C., Ito Y., Miyauchi K., Mikai S., Sagara M., Miyamoto K., Satoh H., Kohno I., Kurata T., Ota H., Mantovani A., Hamakubo T., Daida H., et al. Establishment of high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007, 27:161-167.
17. Matsui S., Ishii J., Kitagawa F., Kuno A., Hattori K., Ishikawa M., Okumura M., Kan S., Nakano T., Naruse H., Tanaka I., Nomura M., Hishida H., Ozaki Y. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 2010, 210:220-225.
18. Latini R., Maggioni A.P., Peri G., Gonzini L., Lucci D., Mocarelli P., Vago L., Pasqualini F., Signorini S., Soldateschi D., Tarli L., Schweiger C., Fresco C., Cecere R., Tognoni G., et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004, 110:2349-2354.
19. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell F.E., Califf R.M., Topol E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996, 335:1333-1341.
20. Antman E.M., Sacks D.B., Rifai N., McCabe C.H., Cannon C.P., Braunwald E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11A substudy. J Am Coll Cardiol 1998, 31:326-330.
21. McCann C.J., Glover B.M., Menown I.B.A., Moore M.J., MaEney J., Owens C.G., Smith B., Sharpe P.C., Young I.S., Adgey J.A. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008, 29:2843-2850.
22. Haltern G., Peiniger S., Bufe A., Reiss G., Gulker H., Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 2010, 105:1-9.
23. Niizeki T., Takeishi Y., Takabatake N., Shibata Y., Konta T., Kato T., Kawata S., Kubota I. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. Circ J 2007, 71:1452-1457.
24. Dekker M.S., Mosterd A., van't Hof A.W., Hoes A.W. Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 2010, 96:1001-1010.
25. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., Budert S., Schaub N., Buerge C., Potocki M., Noveanu M., Bridthardt T., Twerenbold R., Winkler K., Bingisser R., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
26. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., Bickel C., Baldus S., Warnholtz A., Frohlich M., Sinning C.R., Eleftheriadis M.S., Wild P.S., Schnabel R.B., Lubos E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.